117th Congress · SENATE BILLBILL

S. 4348 — FDASLA Act of 2022

“A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.”

Health

Introduced May 26, 2022

Last action Jul 13, 2022

Pipeline · Bill → Law

Step 1

Introduced

May 26, 2022

Step 2

Referred

May 26, 2022

HELP

Step 3

Committee

Jun 14, 2022

Reported out

Step 4

Senate

Jul 13, 2022

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 66 sectionsReported to Senate

7 provisions

6 provisions

7 provisions

6 provisions

7 provisions

2 provisions

18 provisions

7 provisions

1 provision

10 provisions

5 provisions

Timeline · 5 actions

Jul 13, 2022

Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.

Jul 13, 2022

Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Jun 14, 2022

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

May 26, 2022

Introduced in Senate

May 26, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.